Suraksha Diagnostic IPO: The problem opens for subscription on 29 November 2024. Listed below are 10 Key issues to know from the RHP
1.Suraksha Diagnostic IPO: Key dates
On November 29, 2024, the Suraksha Diagnostic IPO shall be out there for subscriptions, and it ends on December 3, 2024. On Wednesday, December 4, 2024, the allocation for the Suraksha Diagnostic IPO is anticipated to be finalized.
2.Suraksha Diagnostic IPO: Measurement
The Suraksha Diagnostic IPO is a ₹846.25 crore book-built providing. The entire challenge is a 1.92 crore share sale provide.
3.Suraksha Diagnostic IPO: Subscription particulars
The value band or pricing vary for the Suraksha Diagnostic IPO is ₹420 to ₹441 per share. An software will need to have a minimal lot dimension of 34 shares. Retail buyers thereby should make a minimal funding of ₹14,994. For giant NII, the minimal lot dimension funding is 67 tons (2,278 shares), or ₹1,004,598, and for small NII, it’s 14 tons (476 shares), or ₹209,916.
4.Suraksha Diagnostic IPO: Itemizing
The Suraksha Diagnostic IPO is a mainboard IPO and Suraksha Diagnostic shares are scheduled to record on the BSE and NSE on Friday, December 6, 2024.
5.Suraksha Diagnostic IPO: Targets of the difficulty
Being an Supply on the market, all proceeds will go to the Promoting Shareholders and Firm won’t obtain any proceeds from the difficulty .
6.About Suraksha Diagnostic Ltd
Suraksha Diagnostic Restricted was established in 2005 and offers medical consulting, radiological testing, and pathology companies. As of June 30, 2024, the it has 215 consumer touchpoints, together with 49 diagnostic facilities and 166 pattern assortment facilities unfold all through West Bengal, Bihar, Assam, and Meghalaya, along with its central reference laboratory and eight satellite tv for pc laboratories.
7. Suraksha Diagnostic IPO; Financials
Suraksha Diagnostic Ltd noticed income elevated by 14.75% and internet revenue surge 281.32% for FY24 in comparison with FY23
8. Suraksha Diagnostic IPO: Promoters
Dr. Somnath Chatterjee, Ritu Mittal and Satish Kumar Verma are the promoters of the corporate
9. Suraksha Diagnostic IPO: Key Dangers
Suraksha Diagnostic’s 95.48% of our Income from Operations in Fiscal 2024 was generated from West Bengal, and any lack of enterprise in such area might have an antagonistic impact on its enterprise, outcomes of operations and monetary situation
10. Suraksha Diagnostic IPO: Lead Managers and Registrars
The Suraksha Diagnostic IPO’s e-book operating lead managers are ICICI Securities Restricted, Nuvama Wealth Administration Restricted, and SBI Capital Markets Restricted. The problem’s registrar is Kfin Applied sciences Restricted.
